Skip to main content
OpenTrials
Completed

NCT Number: NCT04845984

Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Four Hospital of the Alpine Region

The PACAAP study aims to report the seroprevalence of SARS-CoV-2 IgG antibodies among HCWs testing during the massive campaign screening set up in France by French ministry of Health and national authorities in four hospital of the Alpine region.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ch Annecy Genevois

Pringy, 74374, France

About this study

In France during the first wave of the pandemic, 30,230 symptomatic healthcare workers had been reported positive. Yet, the prevalence of the infection in French healthcare workers remains unknown as it mostly reflect symptomatic infections.

Also, the prevalence of infection was reported being higher in male healthcare workers, and in those having patients' facing roles. However, the impact of the level of exposure to SARS-CoV-2, the use of personal protective equipment and hospital organization to prevent infection and spread remains unclear.

Our study aims to report the seroprevalence of SARS-CoV-2 infection among French healthcare workers after the first wave of the pandemic. It also aims to explore the impact of the type of occupations and the level of exposure to the viruses on the seroprevalence of infection.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hospital staff employee
  • Employed in one of the participating centers
  • Volunteers to perform SARS-CoV-2 serology
  • Permanent or occasional staff (temporary workers, short contracts)
  • Caregivers or not (medical, paramedical, administrative, technical staff)

Exclusion criteria

  • Staff who are not working at a participating center while participating in the study
  • Person under guardianship or curatorship
  • Opposition to data collection

Treatment and study plan

Primary outcomes

  1. SARS-CoV-2 prevalency among hospital health care professionals

    Time frame: Day 1

    Number of Health Care Worker with an antibody test (IgG) positive for SARS-CoV2

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Annecy Genevois

Other

Registry information

Official study title

Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Five Hospital of the Alpine Region

Acronym: PACAAP

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Apr 15, 2021
Registry last updated
Apr 15, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.